bims-flametCytokines and immunometabolism in metastasis
This report was maintained by Peio Azcoaga, Katholieke Universiteit te Leuven from 2023–04–02 until 2026–04–19.
2026–04–19
2026–04–12
2026–04–05
2026–03–29
2026–03–22
2026–03–15
2026–03–08
2026–03–01
2026–02–22
2026–02–15
2026–02–08
2026–02–01
2026–01–25
2026–01–18
2026–01–11
2026–01–04
2025–12–28
2025–12–21
2025–12–14
2025–12–07
2025–11–30
2025–11–23
2025–11–16
2025–11–09
2025–11–02
2025–10–26
2025–10–19
2025–10–12
2025–10–05
2025–09–28
2025–09–21
2025–09–14
2025–09–07
2025–08–31
2025–08–24
2025–08–17
2025–08–10
2025–08–03
2025–07–27
2025–07–20
2025–07–13
2025–07–06
2025–06–29
2025–06–22
2025–06–15
2025–06–08
2025–06–01
2025–05–25
2025–05–18
2025–05–11
2025–05–04
2025–04–27
2025–04–20
2025–04–13
2025–04–06
2025–03–30
2025–03–23
2025–03–16
2025–03–09
2025–03–02
2025–02–23
2025–02–16
2025–02–09
2025–02–02
2025–01–26
2025–01–19
2025–01–12
2025–01–05
2024–12–29
2024–12–22
2024–12–15
2024–12–08
2024–12–01
2024–11–24
2024–11–17
2024–11–10
2024–11–03
2024–10–27
2024–10–20
2024–10–13
2024–10–06
2024–09–29
2024–09–22
2024–09–15
2024–09–08
2024–09–01
2024–08–25
2024–08–18
2024–08–11
2024–08–04
2024–07–28
2024–07–21
2024–07–14
2024–07–07
2024–06–30
2024–06–23
2024–06–16
2024–06–09
2024–06–02
2024–05–26
2024–05–19
2024–05–12
2024–05–05
2024–04–28
2024–04–21
2024–04–14
2024–04–07
2024–03–31
2024–03–24
2024–03–17
2024–03–10
2024–03–03
2024–02–25
2024–02–18
2024–02–11
2024–02–04
2024–01–28
2024–01–21
2024–01–14
2024–01–07
2023–12–31
2023–12–24
2023–12–17
2023–12–10
2023–12–03
2023–11–26
2023–11–19
2023–11–12
2023–11–05
2023–10–29
2023–10–22
2023–10–15
2023–10–08
2023–10–01
2023–09–24
2023–09–17
2023–09–10
2023–09–03
2023–08–27
2023–08–20
2023–08–13
2023–08–06
2023–07–30
2023–07–23
2023–07–16
2023–07–09
2023–07–02
2023–06–25
2023–06–18
2023–06–11
2023–06–04
2023–05–28
2023–05–21
2023–05–14
2023–05–07
2023–04–30
2023–04–23
2023–04–16
2023–04–09
2023–04–02
Peio Azcoaga now maintains a report bims-spamet on “Spatial metabolomics of T cells” .
Here are the seven most related reports.
 1. 
0000‒00‒00
 Signing up
0000‒00‒00
 Signed up
bims-imicid“Immunometabolism of infection, cancer and immune-mediated disease”, ∼ 30 p.p.i. ∼ 30 papers per issue
 2. 
0000‒00‒00
 Signing up
0000‒00‒00
 Signed up
bims-stacyt“Metabolism and the paracrine crosstalk between cancer and the organism”, ∼ 6 p.p.i. ∼ 6 papers per issue
 3. 
0000‒00‒00
 Signing up
0000‒00‒00
 Signed up
bims-imseme“Immunosenescence and T cell metabolism”, ∼ 18 p.p.i. ∼ 18 papers per issue
 4. 
0000‒00‒00
 Signing up
0000‒00‒00
 Signed up
bims-glucam“Glutamine cancer metabolism”, ∼ 15 p.p.i. ∼ 15 papers per issue
 5. 
0000‒00‒00
 Signing up
0000‒00‒00
 Signed up
bims-carter“CAR-T Therapies”, ∼ 40 p.p.i. ∼ 40 papers per issue
 6. 
0000‒00‒00
 Signing up
0000‒00‒00
 Signed up
bims-exocan“Exosomes roles in cancer”, ∼ 6 p.p.i. ∼ 6 papers per issue
 7. 
0000‒00‒00
 Signing up
0000‒00‒00
 Signed up
bims-meract“Metabolic reprogramming and anti-cancer therapy”, ∼ 15 p.p.i. ∼ 15 papers per issue
This page is being maintained by Thomas Krichel. It was last updated on 2026‒05‒10 at 6:50.